Latest Intelligence on Pharmaceuticals

The following industries match your search criteria:

Published within

« | 1 | » »|

Click here to sort results by relevance. Click on heading titles to sort results by different field.

Type Product title / description Pub Price
Expert View
Expert View

Advair: GlaxoSmithKline to lead the asthma market

New research from Datamonitor has suggested that the asthma/COPD market will enjoy a 35% increase and reach a value of over $18 billion by 2011. This growth will be largely driven by the success of drug delivery technology, rather than novel drug launches. GlaxoSmithKline should therefore be the main beneficiary of this market expansion although its rivals are looking to close the gap.

Published By Datamonitor
24 Oct 2003

« | 1 | » »|

No help is available.